Skip to content

Author

Neeraj Jain

We have 3 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Boosting chemotherapeutic response: Citric acid-coated Mn0.9Zn0.1Fe2O4 nanoparticles mediated magnetic fluid hyperthermia potentiates docetaxel efficacy in LNCaP cells.

Current therapeutic strategies for prostate cancer (PC) are associated with significant adverse effects, drug resistance, and many other limitations. Docetaxel (DTX), a widely used chemotherapeutic agent for PC, requires high doses, often resulting in severe side effects. Combining DTX with hyperthermia has the potenti...

U. Iyer, K. Parekh, Neeraj Jain · 0 citations
Open access Sep 2026

Development of a multiplex quantitative real-time PCR (qPCR) assay for simultaneous detection of Schistosoma haematobium and high-risk human papillomaviruses

Background Female genital schistosomiasis (FGS) and high-risk human papillomavirus (hr-HPV) infections frequently co-occur in sub-Saharan Africa and may jointly contribute to cervical carcinogenesis. However, no existing molecular platform enables simultaneous detection of Schistosoma haematobium and hr-HPV from a sing...

E. T. Donkoh, Isaac Williams, Rita Nyaaba Akologo et al. · 0 citations
Sep 2026

Assessing the pathogenic potential of PIK3CA gene variants in human cancer using a computational approach.

Ten nsSNPs within PIK3CA were consistently predicted to be deleterious across all functional prediction platforms and were found to affect evolutionarily conserved residues or domains, and six variants were further predicted to significantly alter physicochemical protein properties.

Rajtilak Detroja, Joydeep Chakraborty, Mandar Kulkarni et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.